Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 14Colorectal Neoplasms 9Neoplasm Metastasis 3Leukemia, Myeloid, Acute 3Sarcoma, Ewing 2Rectal Neoplasms 2Myelodysplastic Syndromes 2Liver Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Wilms Tumor 1Thrombocytosis 1Solid Tumor 1Small Cell Lung Carcinoma 1Rhabdomyosarcoma 1Renal Insufficiency 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pretreated Metastatic Colorectal Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neuroblastoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Metastatic Solid Malignancies 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

regorafenib 1paclitaxel poliglumex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Advanced Colorectal Cancer × regorafenib × Clear all
NCT06200363 2024-01-11

A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer

West China Hospital

Phase 1 Unknown
15 enrolled
Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡